Holen Sie sich die Stockscreener-App
42.96
7.05%
2.83
Handel nachbörslich:
42.90
-0.06
-0.14%
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Why Is Vera Therapeutics Stock Gaining Tuesday? - Benzinga
VERA Stock Holds Gains As CEO Trims Stake In Form 4 Sale - StocksToTrade
Vera Therapeutics gains FDA nod for TRUTAKNA launch - TipRanks
US FDA approves Vera's kidney disease drug - Reuters
Vera gains after FDA nod for kidney disease therapy - Seeking Alpha
FDA grants accelerated approval to Vera Therapeutics (NASDAQ: VERA) drug TRUTAKNA - Stock Titan
Vera Therapeutics Receives FDA Accelerated Approval for - GlobeNewswire
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy - Yahoo Finance
VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - Stocktwits
'I got back to living my normal life': How Vera Therapeutics' drug renewed a kidney patient ahead of FDA test - The Business Journals
What's Going on with Vera Therapeutics Stock on Monday? - Benzinga
Vera Therapeutics Shares Climb Ahead of FDA Decision on Atacicept (VERA) - Yahoo Finance
Scilex, Vera Therapeutics rise premarket; Strategy gains By Investing.com - Investing.com Canada
Vera Therapeutics stock rises ahead of FDA decision By Investing.com - Investing.com Canada
VERAVera Therapeutics Inc Short Interest - Finviz
Is Vera Therapeutics, Inc. (VERA) A Good Stock To Buy Now? - Yahoo Finance
Vera Therapeutics updates kidney disease pipeline as investors weigh long-term potential - AD HOC NEWS
FDA Progress Could Send This Biotech Stock Soaring To New Heights - Yahoo Finance
Vera Therapeutics (VERA) Declines as Biotech Sector Faces HeadwindsJelly Roll Trade - dars.gov.et
7 FDA decisions to watch for in Q3 - BioSpace
$Vera Therapeutics (VERA.US)$ - Moomoo
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $56 to $90 - Moomoo
VERA Forecast — Price Target — Prediction for 2027 - TradingView
Vera Therapeutics, Inc. Class A Actuals & Estimates (NASDAQ:VERA) - TradingView
Vera Therapeutics Inc (VERA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Raymond James Maintains Vera Therapeutics(VERA.US) With Buy Rating - Moomoo
Form 4 Vera Therapeutics Inc For: 24 June By Investing.com - Investing.com Nigeria
Vera Therapeutics president and CEO Fordyce Marshall sells $701,769 in stock - Investing.com
Vera Therapeutics Insider Sold Shares Worth $701,769, According to a Recent SEC Filing - marketscreener.com
Vera Therapeutics (VERA) CEO sells 18,500 shares under 10b5-1 plan - Stock Titan
Form 144 Vera Therapeutics For: 23 June By Investing.com - Investing.com Australia
VERA (NASDAQ: VERA) plans resale of 74,000 shares via option exercise - Stock Titan
3 biotech firms with major potential catalysts in the coming months - MSN
3 Biotech Firms With Major Potential Catalysts in the Coming Months - MarketBeat
Vera Therapeutics (VERA) Is Up 10.7% After Accelerated FDA Timeline For Atacicept IgAN FilingHas The Bull Case Changed? - Sahm
Vera Therapeutics Inc (VERA) Institutional Confidence - TradingKey
(VERA) Risk Channels and Responsive Allocation - Stock Traders Daily
Vera Therapeutics Inc (VERA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vera Therapeutics Inc (VERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vera Therapeutics Inc (VERA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vera Therapeutics Inc (VERA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vera Therapeutics stock gains 4.13% as Official VeraTx promotes new IgANime accessory features - Traders Union
Vera Therapeutics Inc (VERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vera Therapeutics Inc (VERA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vera Therapeutics Inc (VERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vera Therapeutics (VERA) Appears Attractive After Latest FDA Agreement - Insider Monkey
Insiders At Vera Therapeutics Sold US$1.9m In Stock, Alluding To Potential Weakness - Moomoo
Vera Therapeutics (VERA) Receives a Buy from Wells Fargo - The Globe and Mail
Vera Therapeutics moves closer to full approval for kidney disease drug after FDA alignment - MSN
Will FDA Alignment on Atacicept’s eGFR Plan Reshape Vera Therapeutics’ (VERA) IgA Nephropathy Narrative - Yahoo Finance
CLDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
A Look At Vera Therapeutics (VERA) Valuation After FDA Alignment On Accelerated IgA Nephropathy Trial Analysis - Yahoo Finance
(VERA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (VERA) and Solid Biosciences (SLDB) - The Globe and Mail
Vera Therapeutics grants inducement awards to 10 new employees - scanx.trade
symbol__ Stock Quote Price and Forecast - CNN
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):